Catalyst Wire Dossier Catalyst Wire Dossier

Kinpeygo

budesonide · Stada Arzneimittel AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kinpeygo, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: EMA Authorised: Kinpeygo (budesonide, micronised) — Stada Arzneimittel AG

See pricing